about
A novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasia.Progranulin gene variability and plasma levels in bipolar disorder and schizophrenia.Mir-223 regulates the number and function of myeloid-derived suppressor cells in multiple sclerosis and experimental autoimmune encephalomyelitis.Immunotherapy against amyloid pathology in Alzheimer's disease.Profiling of ubiquitination pathway genes in peripheral cells from patients with frontotemporal dementia due to C9ORF72 and GRN mutations.Inflammatory molecules in Frontotemporal Dementia: cerebrospinal fluid signature of progranulin mutation carriers.Usefulness of Multi-Parametric MRI for the Investigation of Posterior Cortical Atrophy.The impact of osteopontin gene variations on multiple sclerosis development and progression.Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patientsCerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status.Disease-modifying drugs in Alzheimer's disease.Performance and complications of lumbar puncture in memory clinics: Results of the multicenter lumbar puncture feasibility study.Partial recovery after severe immune reconstitution inflammatory syndrome in a multiple sclerosis patient with progressive multifocal leukoencephalopathy.Circulating miRNAs as potential biomarkers in Alzheimer's disease.Word and Picture Version of the Free and Cued Selective Reminding Test (FCSRT): Is There Any Difference?The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patients.Balò's concentric sclerosis: still to be considered as a variant of multiple sclerosis?Genetics and expression analysis of the specificity protein 4 gene (SP4) in patients with Alzheimer's disease and frontotemporal lobar degeneration.Early onset behavioral variant frontotemporal dementia due to the C9ORF72 hexanucleotide repeat expansion: psychiatric clinical presentations.Merkel cell carcinoma in a patient with relapsing-remitting multiple sclerosis treated with fingolimod.The novel GRN g.1159_1160delTG mutation is associated with behavioral variant frontotemporal dementia.Expression of the transcription factor Sp1 and its regulatory hsa-miR-29b in peripheral blood mononuclear cells from patients with Alzheimer's disease.A 66-year-old patient with vanishing white matter disease due to the p.Ala87Val EIF2B3 mutationPhenotypic Heterogeneity of the GRN Asp22fs Mutation in a Large Italian KindredSciatic endometriosis presenting as periodic (catamenial) sciatic radiculopathyAlzheimer’s Disease: Clinical Aspects and Treatments
P50
Q30402493-E7F9712B-4D9D-4D35-AB13-10AC20CC38B9Q31055209-61E1E02E-3439-4841-A82A-E32C191C3C00Q33653403-9C570DDD-34D6-414B-9DA0-AC4CD5588A1EQ34539482-C5206829-EE2A-4687-83C1-76AFE844FCCDQ35016596-514DC879-7F4F-4BF0-8819-CFE734864871Q35645372-7F36D5CA-2625-439E-90D5-E9775F643B86Q35812786-3552B50B-57D1-4342-AD74-DFDE1A0A8FF7Q36247916-2B4990B0-E37F-44A8-985C-2E4FFADFFABCQ36792169-CDBC95ED-E858-459E-8063-BCF9E899BA2EQ36901561-0F02F1D7-276D-4074-BCCA-6F4AA0501935Q37390739-04F3E2D3-DDD0-486F-BF24-FAD938A04FF4Q41362886-1478AEBF-E334-4034-8D21-474361D1F073Q42248880-E22F99B8-470D-40CD-85B5-8AD76E002927Q44261737-8A4F4373-BA9E-4711-B84F-E6624F8AFDB7Q47975609-BE6CCCB3-4ADF-468F-B426-30D7B80746E9Q47975873-969398B9-61A8-430D-99D4-A59F11B23C18Q48110734-4FC99521-D626-4FA2-9BEF-E4AF65C1097AQ48499483-DCD299D6-E154-4233-A1AC-15D97D46A4C4Q48522755-496DFF6F-0462-4D39-988C-42E071D746C6Q49388044-F91CB612-52FB-4B4D-BED8-878FEE29B335Q50620554-18FF30BE-47C6-4E91-9C91-B588A04EDDBBQ53448282-DC8211F4-E5CD-463C-80E1-9DFDC2282A4CQ57898470-B2B4A1A2-9634-4628-A794-EC891C9512C0Q57898498-C116A5D5-E9C5-42C2-A4EA-C3483D47C530Q59543678-20CC48F2-EA13-4833-8009-28B889AE87A2Q59901826-BE4F5DCA-DB4A-4F71-BEA2-C426E1B4634B
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
L Ghezzi
@nl
Laura Ghezzi
@en
Laura Ghezzi
@es
type
label
L Ghezzi
@nl
Laura Ghezzi
@en
Laura Ghezzi
@es
altLabel
L Ghezzi
@en
prefLabel
L Ghezzi
@nl
Laura Ghezzi
@en
Laura Ghezzi
@es
P106
P1153
54880204500
P21
P31
P496
0000-0001-8180-9730